Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dar Aldawa Dv/Iv | Amman | Healthcare | Pharmaceuticals | JOD 40.60M | 10.6x | 0.7 | JOD 1.16 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Consulting Group | Amman | Healthcare | Healthcare Providers & Services | JOD 34M | 21.3x | 0.47 | JOD 1.70 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hayat Phat | Amman | Healthcare | Pharmaceuticals | JOD 27.07M | 7.9x | 0.2 | JOD 2.85 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ibn Alhaytham H. | Amman | Healthcare | Healthcare Providers & Services | JOD 13.80M | -696.3x | -7.02 | JOD 0.69 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Philadelphia Pharma Industry | Amman | Healthcare | Pharmaceuticals | JOD 10.95M | 13.3x | 5.02 | JOD 1.46 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |